Description: In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Exchange: MX
Country: MX
Currency: Mexican Peso (₱)
Category: Health
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 97.32 | 0.00 | 97.32 |
| Stock non-US | 2.63 | 0.00 | 2.63 |
| Cash | 0.05 | 0.00 | 0.05 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 100.00 | 99.57 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 97.37 | 92.60 |
| Europe Developed | 2.35 | 4.28 |
| United Kingdom | 0.28 | 1.65 |
| Japan | 0.00 | 0.54 |
| Australasia | 0.00 | 0.11 |
| Asia Emerging | 0.00 | 0.82 |
| Africa/Middle East | 0.00 | 0.02 |